Ira Seth Winer, Minal A. Barve, Diane M. Provencher, Manish R. Sharma, Christian Marsolais, Kathya Daigle, Lynn Marie Douglas, Funda Meric-Bernstam. "Efficacy and safety data from Ph1b, dose optimization trial of two doses of TH1902 (sudocetaxel zendusortide), a novel SORT1-targeting peptide drug conjugate (PDC), administered weekly vs q3weekly in patients (pts) with advanced ovarian cancer.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e15113